The sequence of revascularization in liver transplantation: It does make a difference
Wojciech G. Polak, Robert J. Porte – 20 October 2006
Holey endothelium: Gateways for naïve T cell activation
Erin F. McAvoy, Paul Kubes – 20 October 2006
Splendid isolation
Adrian Reuben – 20 October 2006
Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis
Pierre J. Zindy, Annie L'Helgoualc'h, Dominique Bonnier, Antony Le Béchec, Katia Bourd‐Boitin, Chang Xian Zhang, Orlando Musso, Denise Glaise, Marie Bérangère Troadec, Olivier Loréal, Bruno Turlin, Jean Léger, Bruno Clément, Nathalie Théret – 20 October 2006 – The molecular mechanisms underlying the progression of cirrhosis toward hepatocellular carcinoma were investigated by a combination of DNA microarray analysis and literature data mining.
Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference
Benjamin L. Shneider, Regino González‐Peralta, Eve A. Roberts – 20 October 2006
Fatal GvHD as a complication of liver transplantation for undetermined fulminant hepatic failure and associated aplastic anemia
Michela G. Schäppi, Dominique C. Belli, Peter C. Rimensberger, Christophe Chardot, Gürkan Kaya, Jean‐Marie Tiercy, Hulya Ozsahin – 20 October 2006 – Fulminant hepatic failure of unknown origin is the most common cause of fulminant hepatitis with high incidence of aplastic anaemia. Furthermore, the association of liver failure and aplastic anaemia has an increased mortality rate. In this report we describe a 16‐month‐old boy who presented with aplastic anaemia preceding a non‐A, non‐B, non‐C fulminant liver failure.
Role of cytokine gene polymorphism in recurrent HCV infection after liver transplantation
Ziv Ben‐Ari – 20 October 2006
IL‐2 receptor α−/− mice and the development of primary biliary cirrhosis
Kanji Wakabayashi, Zhe‐Xiong Lian, Yuki Moritoki, Ruth Y. Lan, Koichi Tsuneyama, Ya‐Hui Chuang, Guo‐Xiang Yang, William Ridgway, Yoshiyuki Ueno, Aftab A. Ansari, Ross L. Coppel, Ian R. Mackay, M. Eric Gershwin – 20 October 2006 – Recently, we identified a child born with a genetic deficiency of IL‐2 receptor α (IL‐2Rα, CD25) expression who had several clinical manifestations of primary biliary cirrhosis (PBC).
HCV kinetics, quasispecies, and clearance in treated HCV‐infected and HCV/HIV‐1‐coinfected patients with hemophilia
Norah J. Shire, Paul S. Horn, Susan D. Rouster, Sandra Stanford, M. Elaine Eyster, Kenneth E. Sherman, Multicenter Hemophilia Cohort HCV Study Group – 20 October 2006 – Hepatitis C virus (HCV) treatment response rates remain low in HCV/HIV‐1‐coinfected individuals compared with those with HCV alone. Persons with inherited coagulation disorders have high rates of HCV and HIV‐1 infection, but HCV treatment trials in this patient population are scarce.
Protection against Western diet–induced obesity and hepatic steatosis in liver fatty acid–binding protein knockout mice
Elizabeth P. Newberry, Yan Xie, Susan M. Kennedy, Jianyang Luo, Nicholas O. Davidson – 20 October 2006 – Liver fatty acid–binding protein (L‐Fabp) regulates murine hepatic fatty acid trafficking in response to fasting. In this study, we show that L‐Fabp−/− mice fed a high‐fat Western diet for up to 18 weeks are less obese and accumulate less hepatic triglyceride than C57BL/6J controls. Paradoxically, both control and L‐Fabp−/− mice manifested comparable glucose intolerance and insulin resistance when fed a Western diet.